Future Microbiology · 2017 · 13 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyAntimicrobial PharmacologyDrug DesignDrug DiscoveryAntibacterial PharmacologyAntimicrobial PharmacodynamicsDrug-susceptible Tuberculosis TreatmentNatural Product Drug DiscoveryTuberculosis PharmacotherapyBactericidal AgentsCombination Therapy For TuberculosisConcentration-dependent ActivityDrug-resistant PathogensMurine ModelsMycobacterium Tuberculosis InfectionSpecific Activity DeterminationTuberculosis Drug Resistance
AIM: Our objective was to identify a more potent curcumin derivative with specific activity against Mycobacterium tuberculosis. MATERIALS & METHODS: A total of 21 curcumin derivatives were synthesized and detailed bio-evaluation was carried out including determination of static/cidality, synergy with front-line antituberculosis drugs and determination of efficacy in the murine model of M. tuberculosis infection. RESULTS: We identified CPMD-6d dihydrochloride exhibiting concentration-dependent bactericidal activity against M. tuberculosis (MIC 2 μg/ml), even against drug-resistant strains. In addition, it synergizes with front-line antituberculosis drugs as well as significantly reduces bacterial load in mice lungs and spleen at 25 mg/kg as compared with ethambutol at 100 mg/kg. CONCLUSION: Taken together, CPMD-6d dihydrochloride exhibits all properties to be positioned as a novel molecule of interest for treatment of tuberculosis. Graphical abstract: [Formula: see text].
14
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text